7,297
Views
256
CrossRef citations to date
0
Altmetric
Short Communications

Comparative marker analysis of extracellular vesicles in different human cancer types

, , , , &
Article: 20424 | Received 13 Jan 2013, Accepted 09 May 2013, Published online: 18 Jun 2013

References

  • Bobrie A, Colombo M, Raposo G, Théry C. Exosome secretion: molecular mechanisms and roles in immune responses. Traffic. 2011; 12: 1659–68.
  • Schorey JS, Bhatnagar S. Exosome function: from tumor immunology to pathogen biology. Traffic. 2008; 9: 871–81.
  • van Niel G, Porto-Carreiro I, Simoes S, Raposo G. Exosomes: a common pathway for a specialized function. J Biochem. 2006; 140: 13–21.
  • Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013; 200: 373–83.
  • Katsuda T, Kosaka N, Takeshita F, Ochiya T. The therapeutic potential of mesenchymal stem cell-derived extracellular vesicles. Proteomics. 2013; 13: 1637–53.
  • Alvarez-Erviti L, Seow Y, Schapira AH, Gardiner C, Sargent IL, Wood MJ, etal. Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission. Neurobiol Dis. 2011; 42: 360–7.
  • Atay S, Gercel-Taylor C, Kesimer M, Taylor DD. Morphologic and proteomic characterization of exosomes released by cultured extravillous trophoblast cells. Exp Cell Res. 2011; 317: 1192–202.
  • Bhatnagar S, Shinagawa K, Castellino FJ, Schorey JS. Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo. Blood. 2007; 110: 3234–44.
  • Bobrie A, Krumeich S, Reyal F, Recchi C, Moita LF, Seabra MC, etal. Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression. Cancer Res. 2012; 72: 4920–30.
  • Clayton A, Turkes A, Dewitt S, Steadman R, Mason MD, Hallett MB. Adhesion and signaling by B cell-derived exosomes: the role of integrins. FASEB J. 2004; 18: 977–9.
  • Demory Beckler M, Higginbotham JN, Franklin JL, Ham AJ, Halvey PJ, etal. Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. Mol Cell Proteomics. 2013; 12: 343–55.
  • Logozzi M, De Milito A, Lugini L, Borghi M, Calabrò L, Spada M, etal. High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS One. 2009; 4: e5219.
  • Lu Q, Zhang J, Allison R, Gay H, Yang W-X, Bhowmick Na, etal. Identification of extracellular delta-catenin accumulation for prostate cancer detection. Prostate. 2009; 69: 411–8.
  • Lv L-H, Wan Y-L, Lin Y, Zhang W, Yang M, Li G-L, etal. Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro. J Bio Chem. 2012; 287: 15874–85.
  • Peinado H, Alečković M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, etal. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med. 2012; 18: 883–91.
  • Qu J-L, Qu X-J, Zhao M-F, Teng Y-E, Zhang Y, Hou K-Z, etal. Gastric cancer exosomes promote tumour cell proliferation through PI3K/Akt and MAPK/ERK activation. Dig Liver Dis. 2009; 41: 875–80.
  • Théry C, Regnault A, Garin J, Wolfers J, Zitvogel L, Ricciardi-Castagnoli P, etal. Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J Cell Biol. 1999; 147: 599–610.
  • Bobrie A, Colombo M, Krumeich S, Raposo G, Théry C. Diverse subpopulations of vesicles secreted by different intracellular mechanisms are present in exosome preparations obtained by differential ultracentrifugation. J Extracell Vesucles. 2012; 1 18397, doi: http://dx.doi.org/10.3402/jev.v1i0.18397.
  • Bard MP, Hegmans JP, Hemmes A, Luider TM, Willemsen R, Severijnen L-A, etal. Proteomic analysis of exosomes isolated from human malignant pleural effusions. Am J Respir Cell Mol Biol. 2004; 31: 114–21.
  • Mears R, Craven R, Hanrahan S, Totty N, Upton C, Young SL, etal. Proteomic analysis of melanoma-derived exosomes by two-dimensional polyacrylamide gel electrophoresis and mass spectrometry. Proteomics. 2004; 4: 4019–31.
  • Welton JL, Khanna S, Giles PJ, Brennan P, Brewis IA, Staffurth J, etal. Proteomics analysis of bladder cancer exosomes. Mol Cell Proteomics. 2010; 9: 1324–38.
  • Street JM, Barran PE, Mackay CL, Weidt S, Balmforth C, Walsh TS, etal. Identification and proteomic profiling of exosomes in human cerebrospinal fluid. J Transl Med. 2012; 10: 5.
  • Gatti J-L, Métayer S, Belghazi M, Dacheux F, Dacheux J-L. Identification, proteomic profiling, and origin of ram epididymal fluid exosome-like vesicles. Biol Reprod. 2005; 72: 1452–65.
  • Mathivanan S, Simpson RJ. ExoCarta: a compendium of exosomal proteins and RNA. Proteomics. 2009; 9: 4997–5000.
  • Simpson RJ, Kalra H, Mathivanan S. ExoCarta as a resource for exosomal research. J Extracell Vesicles. 2012; 1 18374, doi: http://dx.doi.org/10.3402/jev.v1i0.18374.
  • Vallhov H, Gutzeit C, Johansson SM, Nagy N, Paul M, Li Q, etal. Exosomes containing glycoprotein 350 released by EBV-transformed B cells selectively target B cells through CD21 and block EBV infection in vitro. J Immunol. 2011; 186: 73–82.
  • Aliotta JM, Lee D, Puente N, Faradyan S, Sears EH, Amaral A, etal. Progenitor/stem cell fate determination: interactive dynamics of cell cycle and microvesicles. Stem Cells Dev. 2012; 21: 1627–38.
  • Segura E, Amigorena S, Théry C. Mature dendritic cells secrete exosomes with strong ability to induce antigen-specific effector immune responses. Blood Cells Mol Dis. 2005; 35: 89–93.
  • Llorente A, Marco MCD, Alonso MA. Caveolin-1 and MAL are located on prostasomes secreted by the prostate cancer PC-3 cell line. J Cell Sci. 2004; 117: 5343–51.
  • Jung K-K, Liu X-W, Chirco R, Fridman R, Kim H-RC. Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein. EMBO J. 2006; 25: 3934–42.
  • Hotta H, Ross AH, Huebner K, Hotta H, Ross AH, Huebner K, etal. Molecular cloning and characterization of an antigen associated with early stages of melanoma tumor progression molecular cloning and characterization of an antigen associated with early stages of melanoma tumor progression. Cancer Res. 1988; 2955–62.
  • Kwon MS, Shin S-H, Yim S-H, Lee KY, Kang H-M, Kim T-M, etal. CD63 as a biomarker for predicting the clinical outcomes in adenocarcinoma of lung. Lung Cancer. 2007; 57: 46–53.